NextCure, Inc. (NXTC) financial statements and ratios from SEC XBRL: revenue $22.38M (TTM), net margin -163.6%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $22.38M |
| Net Margin | -163.6% |
| Price / Book | 2.40 |
| Sector P/E (Healthcare) | 21.7 |
NXTC overview · NXTC earnings · NXTC KPIs · NXTC investor relations · NXTC ownership · NXTC peers · NXTC filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.